Research to Improve Vaccines and Therapeutics Awarded
NIH is launching a new nationwide research initiative to define changes in the human immune system and the responses to infection and vaccination, using human and not animal studies. The Recovery Act is funding the first year of the research in which six U. S.-based Human Immune Phenotyping Centers will receive a total of $100 million over five years.
“Recognizing the differences in immune system activity before, during and after exposure to an infectious agent or vaccine will help in the development of safer, more effective therapeutics and vaccines,” says NIAID Director Anthony S. Fauci, M.D.”
Please Note: The Recovery Board has extended the reporting period through Wednesday, October 13th. Please note that this extension is not the same length as in previous quarters, but does provide additional time.
The above funding level for Improving and Preserving Health Care, Health IT, and Children and Community Services are estimates as of June 10, 2010. These estimates are being further refined and the chart will be updated when new estimates are available.
Most of Recovery Act funding will go to States, Territories, and Tribes, who will in turn distribute funds through grants, contracts, subsidies, loan programs, etc. Be sure to check your State Web site for information. Additionally, check the list of State Recovery sites for a link to your state.
Grants announced at the Federal level are announced on Grants.gov.
To learn if you are eligible to receive government benefits, visit GovBenefits.gov. Government loans are available at GovLoans.gov.
Federal contracting opportunities are listed at FedBizOps.
Download Reader
Text
